G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells : caveolin-1 as a marker of cytotoxicity.
|Authors:||Roussel, Élise; Bélanger, Martin; Couët, Jacques|
|Abstract:||Caveolins are highly expressed in terminally differentiated cells, but this expression is down-regulated in various cancer cell lines. Exposure to low doses of paclitaxel (taxol) is sufficient to up-regulate caveolin-1, suggesting that a mild cytotoxic stress induces a response implying caveolin and caveolae. Here we show that this up-regulation is sustained even after the cessation of paclitaxel treatment. After exposure to a cytostatic dose of paclitaxel (50 nM), A549 lung cancer cells are blocked in the G2/M cell cycle phase. After removal of paclitaxel, cell death occurs, accompanied with an increase in caveolin expression, suggesting an effect of caveolin in this process. Three days post-paclitaxel treatment, surviving A549 cells were passaged and only a half of them adhered to the culture dish. Adhering cells (still mainly in the G2/M cell cycle phase) were still unable to grow and progressively entered in an apoptotic state. This study suggests that effects of a low dose of paclitaxel were still present even 1 week after drug removal and that caveolin-1 is a good marker of cytotoxicity.|
|Document Type:||Article de recherche|
|Issue Date:||1 November 2004|
|Open Access Date:||14 November 2017|
|This document was published in:||Anti-cancer drugs, Vol. 15 (10), 961-967 (2004)|
Rapid Communications of Oxford
|Collection:||Articles publiés dans des revues avec comité de lecture|
Files in this item:
|8.pdf||442.71 kB||Adobe PDF||View/Open|
|Finales.pdf||802.2 kB||Adobe PDF||View/Open|
All documents in CorpusUL are protected by Copyright Act of Canada.